Allan Wu's Biography

Allan Wu, Chief Scientific Officer, The Morrow Institute

Dr. Allan Wu is an Aesthetic Reconstructive Cosmetic Surgeon with formal fellowship background training in Surgical Molecular and Cellular Biology from UCLA and Molecular Embryology from the Bourn Hall Clinic in Cambridge U.K. (home of the world’s first “test tube baby”). He is also a board certified tissue banking specialist and cryobiologist. He has worked extensively with the American Association of Tissue Banks in formulating early recommendations for proper tissue banking of adult mesenchymal stem cells. He is currently tenured as director of Women’s Health and Surgery, Regenerative Medicine and Chief Scientific Officer at Regenerative Surgery Institute

Day 2 Clinical Practicum.

Tuesday, 23 April 2013 at 18:00

Add to Calendar ▼2013-04-22 17:30:002013-04-22 18:30:00Europe/LondonClinical Practicum: Delegate Viewing of Reconstructive Surgery ProceduresClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Live patient demonstration of:

PRP use in joints. Pain Management and Rehabilitation Medicine Perspective. (attendees will work with live biologic specimens and learn expert injection methods with Dr. Albert Lai)
Bone Marrow Stem Cell collection and deployment for Orthopedic Applications. (attendees will work with unique collection and harvest sets pioneered by expert regenerative orthopedic surgeon Dr. Wade McKenna and learn expert injection methods first hand)

ADSC: Lowest Lying Fruit or Lowest Shelved Pandora’s Box? Negotiating a safe, legal and ethical pathway for ADSC use in the United States

Monday, 22 April 2013 at 09:00

Although the regulatory environment for adipose adult mesenchymal stem cells is still in a phase of “ripeness”, some general guidelines for clinicians have finally come into focus. For example, following the recent US District Court ruling of Regenerative Sciences vs. the FDA, it is clear that any cell culture for immediate autologous use is considered beyond the scope of minimal manipulation. Furthermore, formal inquiries to the FDA that have come into the public domain indicate some forms of cell assisted lipotransfer (CAL) may also be deemed beyond minimal manipulation. Still questions remain. What is allowable and what is considered safe and within standard of care and how can a practitioner continue to operate given the recent regulatory climate? A suggested best practice method will be presented during this lecture to help clinicians negotiate a safe, legal and ethical pathway for practice within the United States. A detailed discussion of 21 CFR 1271 and potential scientific remedies to address safety, efficacy and minimal manipulation documentation will also be provided.

Clinical Practicum: Delegate Viewing of Reconstructive Surgery Procedures

Monday, 22 April 2013 at 17:30

Dr. Allan Wu, CSO of The Morrow Institute will lead a clinical hands-on practicum focused on providing delegates a real-time, hands-on opportunity to understand trends in stem cells-based clinical practice. This Clinical Practicum will be held at The Morrow Institute (Rancho Mirage, CA).

Live patient demonstration of:

Nutational infrasonic liposuction: harvest and processing of fat graft and SVF (attendees are encourage to bring their own scrubs and experience the device “hands-on” in the operating room, Drs. Morrow, Bircoll, Wu)
GMP lab and sterile technique: how to work within standard laminar flow hoods and routine cell handling devices (attendees will experience first hand rigid standards necessary to handle specimens in a true GMP sterile fashion)
Analytical experience: how to use various cell counting equipment for documentation purposes.

Add to Calendar ▼2013-04-22 00:00:002013-04-23 00:00:00Europe/LondonClinical Translation of Stem Cells SummitClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors